128 related articles for article (PubMed ID: 12587830)
21. Autoimmune thrombocytopenia in two patients with Sneddon's Syndrome.
Meyer O; Worm M; Kiesewetter H; Salama A
Thromb Haemost; 2007 Dec; 98(6):1368-70. PubMed ID: 18064338
[No Abstract] [Full Text] [Related]
22. Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?
Miret C; Cervera R; Reverter JC; García-Carrasco M; Ramos M; Mollà M; Font J; Ingelmo M
Clin Exp Rheumatol; 1997; 15(5):541-4. PubMed ID: 9307863
[TBL] [Abstract][Full Text] [Related]
23. Anticardiolipin and anti-β2glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: more than calculating the in-house 99th percentiles, even for new automated assays.
Devreese KM; Van Hoecke F
Thromb Res; 2011 Dec; 128(6):598-600. PubMed ID: 21762962
[No Abstract] [Full Text] [Related]
24. Progressive supranuclear palsy.
Pahwa R
Med Clin North Am; 1999 Mar; 83(2):369-79, v-vi. PubMed ID: 10093583
[TBL] [Abstract][Full Text] [Related]
25. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
[TBL] [Abstract][Full Text] [Related]
26. Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
Lehéricy S; Hartmann A; Lannuzel A; Galanaud D; Delmaire C; Bienaimée MJ; Jodoin N; Roze E; Gaymard B; Vidailhet M
Brain; 2010 Aug; 133(Pt 8):2410-25. PubMed ID: 20826434
[TBL] [Abstract][Full Text] [Related]
27. International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: report from the 13th International Congress on Antiphospholipid Antibodies.
Lakos G; Favaloro EJ; Harris EN; Meroni PL; Tincani A; Wong RC; Pierangeli SS
Arthritis Rheum; 2012 Jan; 64(1):1-10. PubMed ID: 21953634
[No Abstract] [Full Text] [Related]
28. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
[TBL] [Abstract][Full Text] [Related]
29. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
[TBL] [Abstract][Full Text] [Related]
30. [Steele-Richardson-Olszewski syndrome. Progressive supranuclear paresis].
Sørensen TT
Ugeskr Laeger; 1991 Dec; 153(49):3469-71. PubMed ID: 1776179
[TBL] [Abstract][Full Text] [Related]
31. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 18-1999. A 54-year-old woman with acute renal failure and thrombocytopenia.
N Engl J Med; 1999 Jun; 340(24):1900-8. PubMed ID: 10369854
[No Abstract] [Full Text] [Related]
32. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
[TBL] [Abstract][Full Text] [Related]
33. Progressive supranuclear palsy.
Venmans A; Nijssen PC; Sluzewski M; van Rooij WJ
JBR-BTR; 2009; 92(3):182-3. PubMed ID: 19670589
[No Abstract] [Full Text] [Related]
34. Hepatolenticular degeneration combined with primary antiphospholipid syndrome: a case report.
Atanassova PA; Panchovska MS; Tzvetanov P; Chalakova NT; Masaldzhieva RI; Dimitrov BD
Eur Neurol; 2006; 55(1):42-3. PubMed ID: 16479119
[No Abstract] [Full Text] [Related]
35. Superficial thrombophlebitis of the chest wall associated with anticardiolipin antibodies: antiphospholipid syndrome or Mondor's disease?
Boehlen F; Bader M; de Moerloose P
Lupus; 2004; 13(1):70-1. PubMed ID: 14870921
[No Abstract] [Full Text] [Related]
36. Creutzfeldt-Jakob disease with slow progression. A mimickry of progressive supranuclear palsy.
Huber FM; Bour F; Sazdovitch V; Hauw JJ; Heinemann U; Zanini F; Droste DW; Diederich NJ
Bull Soc Sci Med Grand Duche Luxemb; 2007; (2):125-30. PubMed ID: 18084908
[TBL] [Abstract][Full Text] [Related]
37. Transient low levels of antibodies at initial presentation of primary anti-phospholipid syndrome.
Divate S; Hardikar P; Bichile LS; Rajadhyaksha A
J Assoc Physicians India; 2003 Jul; 51():722-3. PubMed ID: 14621047
[TBL] [Abstract][Full Text] [Related]
38. Limited effect of rituximab on thrombocytopaenia and anticardiolipin antibodies in a patient with primary antiphospholipid syndrome.
Ames PR; Tommasino C; Fossati G; Scenna G; Brancaccio V; Ferrara F
Ann Hematol; 2007 Mar; 86(3):227-8. PubMed ID: 17119963
[No Abstract] [Full Text] [Related]
39. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of antiphospholipid syndrome.
Bertolaccini ML; Khamashta MA
Expert Rev Hematol; 2008 Dec; 1(2):183-8. PubMed ID: 21082923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
